TRBV26OR9-2

Across TCGA pan-cancer cohorts, TRBV26OR9-2 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated TRBV26OR9-2 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher TRBV26OR9-2 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated TRBV26OR9-2 expression acts as an unfavorable survival marker, although some lineages such as UCS and KIRC show a favorable association.

BLCA, THCA, and UCS are the cancer types where TRBV26OR9-2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.222	0.383	.002	89	view →
THCA	OS	Tertile	IV	0.750	0.972	<.001	63	view →
UCS	DFS	Median	II,III,IV	0.550	0.171	.001	58	view →
UVM	DFS	Tertile	All	0.201	0.785	.001	54	view →
KIRC	OS	Median	All	0.906	0.843	.001	46	view →
ACC	OS	Median	All	0.916	0.719	.006	41	view →
OV	OS	Tertile	III,IV	0.218	0.329	.015	36	view →
STAD	DFS	Tertile	All	0.584	0.802	.006	36	view →
COAD	OS	Tertile	III,IV	0.537	0.826	.001	33	view →
BRCA	DFS	Median	III,IV	0.857	0.755	.017	19	view →
LIHC	OS	Tertile	All	0.184	0.570	.006	15	view →
PAAD	OS	Median	All	0.484	0.323	.017	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

TRBV26OR9-2–BLCA (DFS)

Open the BLCA breakdown →